Key statistics
As of last trade Assembly Biosciences Inc (ASMB:NSQ) traded at 18.63, -7.06% below its 52-week high of 20.04, set on Oct 17, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 18.17 |
---|---|
High | 19.00 |
Low | 18.00 |
Bid | 18.50 |
Offer | 18.74 |
Previous close | 18.17 |
Average volume | 29.03k |
---|---|
Shares outstanding | 6.35m |
Free float | 4.34m |
P/E (TTM) | -- |
Market cap | 115.30m USD |
EPS (TTM) | -9.32 USD |
Data delayed at least 15 minutes, as of Sep 19 2024 16:05 BST.
More ▼
- Assembly Biosciences Reports Second Quarter 2024 Financial Results and Recent Updates
- Assembly Biosciences Presents New Preclinical Data Highlighting Investigational Helicase-Primase Inhibitors at International Herpesvirus Workshop
- Assembly Biosciences Doses First Participant in Phase 1b Clinical Trial Evaluating Next-Generation Capsid Assembly Modulator Candidate ABI-4334 for the Treatment of Chronic Hepatitis B Virus Infection
- Assembly Biosciences Announces $12.6 Million in Equity Financings
- Assembly Biosciences Doses First Participant in Phase 1a/b Clinical Trial of Herpes Simplex Virus Helicase-Primase Inhibitor Candidate ABI-5366
- Assembly Biosciences Presents New Data Highlighting Hepatitis D Virus Entry Inhibitor ABI-6250 at the EASL Congress™ 2024
- Assembly Biosciences to Present Data at Upcoming International Herpesvirus Workshop and EASL Congress™ 2024
- Assembly Biosciences Reports First Quarter 2024 Financial Results and Recent Highlights
- Assembly Biosciences Reports Fourth Quarter and Year End 2023 Financial Results and Recent Highlights
- Assembly Biosciences Announces Effective Date of Reverse Stock Split
More ▼